Select a community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community
Home > Community Treatment Reports > Memantine Treatment Report
What is Memantine?

Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system. It is also being tested for use as a cognitive enhancer in a variety of other conditions. Read more...Click to read more below

Merz's Memantine site

Reasons taken & Efficacy

Reasons and Efficacy
Reasons taken # of patients Major Moderate Slight None Can’t tell # of patients evaluated by
Memory problems 2 1
Dementia 1 1
Stiffness/Spasticity 1 0
Other 1 0

Mouse over the table for more information

Side Effects

Side effects as an overall problem

Severe
0 0%
Moderate
1 50%
Mild
0 0%
None
1 50%

Most commonly reported side effects

Vivid dreams
1 50%
  • Mild
  • Moderate
  • Severe

Dosages

  20 mg as needed 10 mg daily 20 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 6 Number of Patients: 6  

Stop Reasons

Why Patients Stopped Taking Memantine (multiple reasons could be selected)
Reason # Patients Percentage of patients
Did not seem to work
1 100% Did not seem to work: 100%

See all 1 patient who’ve stopped taking Memantine

Duration See details about how long patients take this treatment ▼

Currently Taking Memantine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
2
1

Stopped Taking Memantine

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
1
0
0
0
0
0

Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Always
1 50%
Usually
1 50%
Sometimes
0 0%
Never
0 0%

Burden

Difficulty being on treatment

Very
0 0%
Somewhat
0 0%
A little
1 50%
Not at all
1 50%

Cost

Paid out of pocket

$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
0 0%

Report created on November 21, 2009.